Cargando…
Why do we not have a cure for rheumatoid arthritis?
CHAPTER SUMMARY: There are currently unprecedented opportunities to treat rheumatoid arthritis using well-designed, highly effective, targeted therapies. This will result in a substantial improvement in the outcome of this disorder for most affected individuals, if they can afford these therapies. Y...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240144/ https://www.ncbi.nlm.nih.gov/pubmed/12110149 http://dx.doi.org/10.1186/ar568 |
_version_ | 1782219347783057408 |
---|---|
author | El-Gabalawy, Hani D Lipsky, Peter E |
author_facet | El-Gabalawy, Hani D Lipsky, Peter E |
author_sort | El-Gabalawy, Hani D |
collection | PubMed |
description | CHAPTER SUMMARY: There are currently unprecedented opportunities to treat rheumatoid arthritis using well-designed, highly effective, targeted therapies. This will result in a substantial improvement in the outcome of this disorder for most affected individuals, if they can afford these therapies. Yet our lack of understanding of the basic mechanisms that initiate and sustain this disease remains a major obstacle in the search for a definitive cure. It is possible, if not likely, that our best approach will be to identify individuals at risk and devise reliable, safe methods of preventing the disease before it occurs. The means to do this are currently unknown but should serve as a major focus of research. |
format | Online Article Text |
id | pubmed-3240144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32401442011-12-16 Why do we not have a cure for rheumatoid arthritis? El-Gabalawy, Hani D Lipsky, Peter E Arthritis Res Review CHAPTER SUMMARY: There are currently unprecedented opportunities to treat rheumatoid arthritis using well-designed, highly effective, targeted therapies. This will result in a substantial improvement in the outcome of this disorder for most affected individuals, if they can afford these therapies. Yet our lack of understanding of the basic mechanisms that initiate and sustain this disease remains a major obstacle in the search for a definitive cure. It is possible, if not likely, that our best approach will be to identify individuals at risk and devise reliable, safe methods of preventing the disease before it occurs. The means to do this are currently unknown but should serve as a major focus of research. BioMed Central 2002 2002-05-09 /pmc/articles/PMC3240144/ /pubmed/12110149 http://dx.doi.org/10.1186/ar568 Text en Copyright ©2002 BioMed Central Ltd |
spellingShingle | Review El-Gabalawy, Hani D Lipsky, Peter E Why do we not have a cure for rheumatoid arthritis? |
title | Why do we not have a cure for rheumatoid arthritis? |
title_full | Why do we not have a cure for rheumatoid arthritis? |
title_fullStr | Why do we not have a cure for rheumatoid arthritis? |
title_full_unstemmed | Why do we not have a cure for rheumatoid arthritis? |
title_short | Why do we not have a cure for rheumatoid arthritis? |
title_sort | why do we not have a cure for rheumatoid arthritis? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240144/ https://www.ncbi.nlm.nih.gov/pubmed/12110149 http://dx.doi.org/10.1186/ar568 |
work_keys_str_mv | AT elgabalawyhanid whydowenothaveacureforrheumatoidarthritis AT lipskypetere whydowenothaveacureforrheumatoidarthritis |